XBiotech Inc
Cerrado
2.43 -2.02
Resumen
Variación precio
24h
Mínimo
2.41
Máximo
2.49
Ingresos | -21M -27M |
|---|---|
BPA | -0.882 |
Empleados | 85 |
EBITDA | -24M -29M |
Próximas Ganancias | 19 may 2026 |
|---|
Capitalización Mercado | 3.7M 75M |
|---|---|
Apertura anterior | 4.45 |
Cierre anterior | 2.43 |
Puntuación técnica
By Trading Central
Confianza
Bullish Evidence
XBiotech Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
XBiotech Inc previsión
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.